Biodegradable ureteral stents for the treatment of urothelial tumors of the upper urinary tract cancer

Bibliographic Details
Main Author: Barros, Alexandre António Antunes
Publication Date: 2016
Other Authors: Browne, S., Oliveira, C., Reis, R. L., Lima, E., Duarte, Ana Rita C., Healy, K. E.
Language: eng
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: http://hdl.handle.net/1822/42501
Summary: Publicado em "European cells and materials". ISSN 1473-2262. Vol. 31, suppl. 1 (2016)
id RCAP_684e762df676c8bdd9a13a3a07c7f1b8
oai_identifier_str oai:repositorium.sdum.uminho.pt:1822/42501
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Biodegradable ureteral stents for the treatment of urothelial tumors of the upper urinary tract cancerAnti-cancerBiodegradableUpper urinary tractUreteral stentPublicado em "European cells and materials". ISSN 1473-2262. Vol. 31, suppl. 1 (2016)INTRODUCTION: Biodegradable ureteral stents have proven to be a useful alternative to conventional stents. Furthermore, they can be functionalized as drug eluting stents, especially for urothelial tumors of the upper urinary tract. In these cases, the conventional method of drug administration is via drug instillation. This has several drawbacks, such as high concentration dosage, increased side effects, short residence time and low bioavailability [1]. To avoid these problems, biodegradable ureteral stents impregnated by supercritical fluid CO2 (SCF) with four different anti-cancer drugs were produced. METHODS: Biodegradable ureteral stents were produced according previous work [2]. Four types of drug-eluting biodegradable stents based on natural polymers were prepared. The stents were impregnated by SCF (40°C, 100 bar, 90 min), with paclitaxel, epirubicin, doxorubicin and gemcitabine. The release kinetics of the impregnated drugs from the anti-cancer drugeluting stents was evaluated in artificial urine solution (AUS) for 9 days. The anti-tumoral effect of the developed stents in transitional cell carcinoma (T24) and HUVEC primary cells, used as control, was evaluated. RESULTS: The in vitro release study in AUS showed a sustainable release in the first 72h for the four drugs impregnated, after this time a plateau was achieved and finally the stent degraded after 9 days. To determine the sensitivities to each drug (IC50), a T24 cancer cell line was exposed to graded concentrations (0.01 to 2000 ng/ml) of the four drugs for both 4h and 72h. Additionally, toxicity as a result of both direct and indirect contact of the cell lines with the different material conditions of biodegradable stent were studied. The four anti-cancer drugs studied showed a concentration-dependent inhibitory effect on the T24 and (control) HUVEC cell lines with IC50’s for paclitaxel of 7.30 ng and 501.50 ng, respectively. The T24 cancer cell line was shown to be more sensitive than the control HUVEC cell line for all the anti-cancer drugs tested. DISCUSSION & CONCLUSIONS: The direct and indirect contact of the anti-cancer biodegradable stents with the T24 and HUVEC cells confirm the anti-cancer effect of the stents impregnated with the four anti-cancer drugs, reducing approximately 75% of the viability of the T24 cell line after 72h and no negative effect in the HUVEC cells for the total drug release from stents. This study has thus shown the efficacy of the anticancer drug eluting biodegradable stents in vitro for the T24 cell line, with no toxicity observed in non-cancerous HUVEC cells.FLAD Grant for internship in UC Berkeley 2015/CON5/CAN8APU Grant Jaba Recordati 2015AO FoundationUniversidade do MinhoBarros, Alexandre António AntunesBrowne, S.Oliveira, C.Reis, R. L.Lima, E.Duarte, Ana Rita C.Healy, K. E.2016-072016-07-01T00:00:00Zconference objectinfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://hdl.handle.net/1822/42501engBarros A. A., Browne S., Oliveira C., Duarte A. R. C., Reis R. L., Lima E., Healy K. E. Biodegradable ureteral stents for the treatment of urothelial tumors of the upper urinary tract cancer, TERMIS-EU 2016, Vol. 31, Issue 1, pp. 68, doi:10.1039/C2SM26784E, 2016http://www.ecmjournal.org/journal/supplements/vol031supp01/pdf_posters/Vol031Supp01P068.pdfinfo:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2024-05-11T07:36:07Zoai:repositorium.sdum.uminho.pt:1822/42501Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T16:32:57.328425Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Biodegradable ureteral stents for the treatment of urothelial tumors of the upper urinary tract cancer
title Biodegradable ureteral stents for the treatment of urothelial tumors of the upper urinary tract cancer
spellingShingle Biodegradable ureteral stents for the treatment of urothelial tumors of the upper urinary tract cancer
Barros, Alexandre António Antunes
Anti-cancer
Biodegradable
Upper urinary tract
Ureteral stent
title_short Biodegradable ureteral stents for the treatment of urothelial tumors of the upper urinary tract cancer
title_full Biodegradable ureteral stents for the treatment of urothelial tumors of the upper urinary tract cancer
title_fullStr Biodegradable ureteral stents for the treatment of urothelial tumors of the upper urinary tract cancer
title_full_unstemmed Biodegradable ureteral stents for the treatment of urothelial tumors of the upper urinary tract cancer
title_sort Biodegradable ureteral stents for the treatment of urothelial tumors of the upper urinary tract cancer
author Barros, Alexandre António Antunes
author_facet Barros, Alexandre António Antunes
Browne, S.
Oliveira, C.
Reis, R. L.
Lima, E.
Duarte, Ana Rita C.
Healy, K. E.
author_role author
author2 Browne, S.
Oliveira, C.
Reis, R. L.
Lima, E.
Duarte, Ana Rita C.
Healy, K. E.
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade do Minho
dc.contributor.author.fl_str_mv Barros, Alexandre António Antunes
Browne, S.
Oliveira, C.
Reis, R. L.
Lima, E.
Duarte, Ana Rita C.
Healy, K. E.
dc.subject.por.fl_str_mv Anti-cancer
Biodegradable
Upper urinary tract
Ureteral stent
topic Anti-cancer
Biodegradable
Upper urinary tract
Ureteral stent
description Publicado em "European cells and materials". ISSN 1473-2262. Vol. 31, suppl. 1 (2016)
publishDate 2016
dc.date.none.fl_str_mv 2016-07
2016-07-01T00:00:00Z
dc.type.driver.fl_str_mv conference object
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/1822/42501
url http://hdl.handle.net/1822/42501
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Barros A. A., Browne S., Oliveira C., Duarte A. R. C., Reis R. L., Lima E., Healy K. E. Biodegradable ureteral stents for the treatment of urothelial tumors of the upper urinary tract cancer, TERMIS-EU 2016, Vol. 31, Issue 1, pp. 68, doi:10.1039/C2SM26784E, 2016
http://www.ecmjournal.org/journal/supplements/vol031supp01/pdf_posters/Vol031Supp01P068.pdf
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv AO Foundation
publisher.none.fl_str_mv AO Foundation
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833596015648702464